People | April 04, 2023
Top management changes at IOL Chemicals and Pharmaceuticals
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Getinge has a strong market share in India within several product segments
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Proposed combination enhances Pfizer’s position as a leading company in oncology
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial
Subscribe To Our Newsletter & Stay Updated
